Expression of CYP2E1 during embryogenesis and fetogenesis in human cephalic tissues: Implications for the fetal alcohol syndrome

Biochemical and Biophysical Research Communications

Volumn 238, Issue 2, 1997, Pages 443-447

  Boutelet Bochan, H ^a   Huang, Y ^a   Juchau, M R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COMPLEMENTARY DNA; CYTOCHROME P450; MESSENGER RNA;

ADRENAL GLAND; ALCOHOL METABOLISM; ARTICLE; BRAIN; BRAIN TISSUE; EMBRYO; EMBRYO DEVELOPMENT; EXON; FETAL ALCOHOL SYNDROME; FETUS; FETUS DEVELOPMENT; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LIVER; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL;

EID: 0031577540     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7296     Document Type: Article

References (27)

1. Warner M., Gustafsson J-A. Handbook of Experimental Pharmacology: Cytochrome P450. 1993;Springer Verlag, Berlin. p. 387-397.
2. Ravindranath V., Boyd M. R. Drug Metab. Rev. 27:1995;419-448.
3. Lieber C. S. Physiol. Rev. 77:1997;517-544.
4. Strobel H. W., Geng J., Kawashima H., Wang H. Drug Metab. Rev. 1997.
5. Krauer B., Dayer P. Clin. Pharmacokinet. 21:1991;70-80.
6. Juchau M. R., Lee Q. P., Fantel A. G. Drug Metab. Rev. 24:1992;195-238.
7. Raucy J. L., Carpenter S. J. J. Pharmacol. Toxicol. Meth. 29:1993;121-128.
8. Juchau M. R., Boutelet-Bochan H., Huang Y. Drug Metab. Rev. 1997.
9. Abel E. L., Sokol R. J. Drug Alcohol Depend. 19:1987;51-70.
10. Streissguth A. P., Aase J. M., Clarren S. K., Randels S. P., LaDue R. A., Smith D. F. J. Am. Med. Assn. 265:1991;1961-1967.
11. Carpenter S. P., Lasker J. M., Raucy J. L. Molec. Pharmacol. 49:1996;260-268.
12. Lindros K. Alcoholism: Clin. Exp. Res. 20:1996;87A-88A.
13. Song B. J., Cederbaum A. I. Alcoholism: Clin. Exp. Res. 20:1996;A138-A146.
14. Pikkarainen P. H. Life Sci. 10:1971;1359-1364.
15. Chomczynski P., Sacchi N. Analyt. Biochem. 162:1987;156-159.
16. Promega Protocols and Application Guide, 1991, 60, 61.
17. Farin F. M., Omiecinski C. J. J. Toxicol. Env. Health. 40:1993;317-335.
18. Schatz D. G. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidmen J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology/Suppl. 21. 1993;2.9.1-2.9.14 Greene and Wiley-Interscience, New York.
19. Sambrook J., Fritsch E. F., Maniatis T. Molecular Biology: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 7.37-7.39.
20. Herrin D. L., Schmidt G. W. Biotechniques. 6:1988;196-200.
21. Carpenter S. P., Lasker J. M., Raucy J. L. Molec. Pharmacol. 49:1996;260-268.
22. Hunt W. A. Alcohol. 13:1996;147-151.
23. Albano E., Clot P., Morimoto M., Tomasi A., Ingelman-Sundberg M., French S. W. Hepatology. 23:1996;155-163.
24. Albano E., Clot P., Eliasson E., Tabone M., Arico S., Israelm Y., Moncada C., Ingelman-Sundberg. Gastroenterol. 111:1996;206-216.
25. Henderson G. I., Devi B. G., Perez A., Schenker S. Alcoholism: Clin. Exp. Res. 19:1995;714-720.
26. Aragon C. M. G., Rogan F., Amit Z. Biochem. Pharmacol. 44:1992;93-98.
27. Zimatkin S. M., Lindros K. O. Alcohol Alcoholism. 31:1996;167-174.